LDR公司开发出部分椎体替代系统 (PVBRs)

部分椎体替代系统(PVBRs)是由一组神经病学和整形外科医生研制开发的，用以解决当前退行性脊椎疾病治疗不尽如人意之处。

这套MC+和ROI系统设计独特，为外科医生提供了广阔的移植区域，这十分重要，可以在椎骨终板最强大区域的承重面放置移植物。这两种系统在设计、材料、安装设备以及使用的方便程度上都具有许多不同之处。

这两套系统都获得了美国食品药品管理局的许可。这些系统都是由法国的LDR医疗公司研制开发的，得到了外科医生的强力支持。迄今为止，这些产品已经在超过3000例的手术中获得了成功应用。在美国这两套系统都是由LDR的美国销售伙伴LDR脊柱公司进行销售。

LDR脊柱公司总裁兼首席执行官Steve Whitlock说：“这两套系统得到了外科学界的广泛认可，因为其简便易用。我们是唯一的脊柱产品公司，可以定制并消毒我们的产品。尽管整个关节市场长期以来就从事这项业务，但是我们是唯一的进行定制和销售脊柱关节产品的公司。”
 
Unique Implants for Spinal Fusion
 
Partial vertebral body replacement systems (PVBRs) were developed by a team of neurologic and orthopedic surgeons to address unmet or underserved needs in the treatment of degenerative spine disease.

The MC+ and ROI systems feature a unique design that provides surgeons with a large grafting area--an important feature that enables placement of the implants--and weight-bearing surfaces on the strongest areas of the vertebral endplate. The two systems offer many areas of differentiation in their design, material, instrumentation, and ease of use.

Both systems have been cleared by the U.S. Food and Drug Administration (FDA). The systems were developed in France by LDR Medical (Troyes, France) with strong surgeon involvement. To date, they have been successfully used in more than 3,000 procedures. Both systems will be distributed in the United States by LDR’s U.S. distribution partner, LDR Spine (Austin, TX, USA).

“Both systems have been well received by the surgeon community because of their simplified instrumentation,” said Steve Whitlock, president and CEO of LDR Spine. “We are the only spine company to individually package and sterilize our products. While the total joint market has long employed this approach, it is only a matter of time before all spine companies’ products are also packaged and delivered this way.”